1–3 of 3 results for Srinivas Reddy Sadda
Assessment on Pre-to-Post Switching Efficacy and Safety of SB15 (Proposed Aflibercept Biosimilar): Post Hoc Analysis of a Phase 3 Clinical Trial
Srinivas Reddy Sadda, MD
Annual Meeting Talks
2024
OCT Biomarkers for Surgical Retinal Disorders
Updates from the Field
2025
Update on Artificial Intelligence Systems for Diabetic Retinopathy
2023